LITTLE KNOWN FACTS ABOUT BOTULAX.

Onset and length are only a perform of the toxin's molecular potency to the point of whole saturation of NMJs. Any quantity of BoNT‐A molecules past the point of saturation will then be unbound and clinically worthless. Larger molecular potency may perhaps improve the volume of adverse situations (AEs), but this is typically dependent on the tech